Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice.
about
STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia.Increased cytotoxic effects of photodynamic therapy in IL-6 gene transfected cells via enhanced apoptosis.Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling.Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancerRegulation of interleukin-6 secretion from breast cancer cells and its clinical implications.Medroxyprogesterone acetate and cancer cachexia: interleukin-6 involvement.The relationship between weight loss and interleukin 6 in non-small-cell lung cancerMedroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect.Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6.Overweight and obesity predict better overall survival rates in cancer patients with distant metastases.IL-6/IL-6 receptor system and its role in physiological and pathological conditions.Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options.Muscle wasting as main evidence of energy impairment in cancer cachexia: future therapeutic approaches.Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models.Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.Enhancement of in vivo antitumor activity of a novel antimitotic 1-phenylpropenone derivative, AM-132, by tumor necrosis factor-alpha or interleukin-6.Identification of tumor vascular antigens by monoclonal antibodies prepared from rat-tumor-derived endothelial cells.Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo.
P2860
Q31028277-EAB61E53-41AB-49FB-9656-AD83F07D6ED2Q31941540-AA03BCD9-CD2B-4D9E-896E-F945D322E36DQ33700636-E18A0782-E623-4D98-B58E-0A3CD6E03717Q33882832-96ADD772-5F05-4905-A947-62A183737CE4Q34058941-E8103102-5E2F-43D9-BCE2-30702A84CCEDQ34058946-0E881631-0521-425E-8907-DB221C2AC314Q36135375-62037205-49BA-493E-908A-09DC51B6724BQ36618202-3BF42D3D-8141-4189-9DDA-C3AFCFF4073DQ36618907-861123BB-D5B3-473E-8AE9-BB24D5EC0167Q36797278-5119E9ED-115F-4578-9C48-85C4BBBECAB0Q37949664-776AB52D-853F-4BBE-9695-540539FD3F67Q38290238-7ABBD391-E7D1-4F4D-802E-820417DDA55EQ38587970-208F6E3E-99DA-4EEC-B39A-057C9DCF1A9CQ40226137-C4F0DF3A-66C1-41C6-A10C-1D3C19551D76Q40433122-1414B6F6-0DAC-4AF5-93FA-CF17C1FEB2DDQ40789832-BFF7A576-79C9-4835-811B-95C2931FC872Q40849314-702B1705-3C2F-4A54-B219-3425BEF2A4B7Q44580396-F86FCA90-49ED-4EFA-B795-EA2C288CA72C
P2860
Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Interleukin-6 cDNA transfected ...... ed survival in syngeneic mice.
@ast
Interleukin-6 cDNA transfected ...... ed survival in syngeneic mice.
@en
type
label
Interleukin-6 cDNA transfected ...... ed survival in syngeneic mice.
@ast
Interleukin-6 cDNA transfected ...... ed survival in syngeneic mice.
@en
prefLabel
Interleukin-6 cDNA transfected ...... ed survival in syngeneic mice.
@ast
Interleukin-6 cDNA transfected ...... ed survival in syngeneic mice.
@en
P2093
P2860
P356
P1476
Interleukin-6 cDNA transfected ...... ed survival in syngeneic mice.
@en
P2093
E R Podack
Y Koishihara
Y Miyahara
P2860
P2888
P304
P356
10.1038/BJC.1993.174
P407
P577
1993-05-01T00:00:00Z